EDGAR Filing Documents for 0001368993-13-000039

Form 8-K - Current report:

SEC Accession No. 0001368993-13-000039

Filing Date

2013-08-28

Accepted

2013-08-27 21:51:13

Documents

Period of Report

2013-08-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		o82713-8k.htm	8-K	56788
2		ex_3-1.htm	EX-3.1	1577
3		ex_3-1.pdf	EX-3.1	500529
4		ex_3-2.htm	EX-3.2	1596
5		ex_3-2.pdf	EX-3.2	7647208
6		ex_3-3.htm	EX-3.3	1596
7		ex_3-3.pdf	EX-3.3	301979
8		ex_4-1.htm	EX-4.1	126598
9		ex_10-1.htm	EX-10.1	148885
10		ex_10-2.htm	EX-10.2	137562
11		ex_99-1.htm	EX-99.1	15843
	Complete submission text file	0001368993-13-000039.txt		12134173

Mailing Address 7400 PASEO PADRE PARKWAY FREMONT CA 94555

Business Address 7400 PASEO PADRE PARKWAY FREMONT CA 94555 (510) 651-4450

WaferGen Bio-systems, Inc. (Filer) CIK: 0001368993 (see all company filings)